✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Lyka Labs Ltd.

LYKALABS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹259 Cr.
P/E
0.00

Lyka Labs Ltd.

  • Lyka Labs
  • Vaidya Sane Ayur Lab
  • Gennex Lab

FAQs on Lyka Labs Ltd. Shareprice

Lyka Labs has given lower returns compared to its competitors.
Lyka Labs has grown at ~-17.81% over the last 3yrs while peers have grown at a median rate of 5.1%

Lyka Labs is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Lyka Labs is 0, while 3 year average PE is 80.3.
Also latest EV/EBITDA of Lyka Labs is 42.25 while 3yr average is 21.54.

View FAQ's On Business

Growth Table

  • Lyka Labs Ltd.
  • Vaidya Sane Ayur Lab
  • Gennex Lab

Balance Sheet

  • Lyka Labs Ltd.
  • Vaidya Sane Ayur Lab
  • Gennex Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Lyka Labs Ltd.
  • Vaidya Sane Ayur Lab
  • Gennex Lab

Cash Flow

  • Lyka Labs Ltd.
  • Vaidya Sane Ayur Lab
  • Gennex Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Lyka Labs Ltd.
  • Vaidya Sane Ayur Lab
  • Gennex Lab

Quarterly Results

  • Lyka Labs Ltd.
  • Vaidya Sane Ayur Lab
  • Gennex Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Lyka Labs Ltd. Financials

Balance sheet of Lyka Labs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Lyka Labs is decreasing.
Latest net debt of Lyka Labs is ₹29.62 Crs as of Sep-25.
This is less than Mar-25 when it was ₹35.38 Crs.

Yes, profit is increasing.
The profit of Lyka Labs is ₹8.01 Crs for Mar 2025, -₹2.49 Crs for Mar 2024 and -₹13.21 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lyka Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech